Enzolytics Inc. (OTCMKTS: ENZC) Completes Steps Necessary For ITV-1 Medication Production And Clinical Studies Ahead of EMA Approval
Enzolytics Inc. (OTCMKTS: ENZC) has finalized an agreement and arrangements with Danhason and Clinic Design to advance its Anti-HIV treatment ITV—1 into clinical trials and production. These processes are necessary…